These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
434 related articles for article (PubMed ID: 25109332)
1. Geranylgeranylation signals to the Hippo pathway for breast cancer cell proliferation and migration. Mi W; Lin Q; Childress C; Sudol M; Robishaw J; Berlot CH; Shabahang M; Yang W Oncogene; 2015 Jun; 34(24):3095-106. PubMed ID: 25109332 [TBL] [Abstract][Full Text] [Related]
2. The Hippo-YAP/TAZ pathway mediates geranylgeranylation signaling in breast cancer progression. Lin Q; Yang W Mol Cell Oncol; 2016 May; 3(3):e969638. PubMed ID: 27314103 [TBL] [Abstract][Full Text] [Related]
3. Geranylgeranylation promotes proliferation, migration and invasion of gastric cancer cells through the YAP signaling pathway. Wei J; Peng K; Zhu J; Wang L; Han T; Sun A; Shao G; Liu H; Yang W; Lin Q Am J Transl Res; 2020; 12(9):5296-5307. PubMed ID: 33042420 [TBL] [Abstract][Full Text] [Related]
4. MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells. Heidary Arash E; Shiban A; Song S; Attisano L EMBO Rep; 2017 Mar; 18(3):420-436. PubMed ID: 28183853 [TBL] [Abstract][Full Text] [Related]
5. MEKK2 and MEKK3 orchestrate multiple signals to regulate Hippo pathway. Lu J; Hu Z; Deng Y; Wu Q; Wu M; Song H J Biol Chem; 2021; 296():100400. PubMed ID: 33571521 [TBL] [Abstract][Full Text] [Related]
6. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway. Hori N; Okada K; Takakura Y; Takano H; Yamaguchi N; Yamaguchi N J Biol Chem; 2020 Jun; 295(26):8798-8807. PubMed ID: 32385107 [TBL] [Abstract][Full Text] [Related]
7. YAP and TAZ Take Center Stage in Cancer. Zhang K; Qi HX; Hu ZM; Chang YN; Shi ZM; Han XH; Han YW; Zhang RX; Zhang Z; Chen T; Hong W Biochemistry; 2015 Nov; 54(43):6555-66. PubMed ID: 26465056 [TBL] [Abstract][Full Text] [Related]
8. The regulatory mechanisms and functional roles of the Hippo signaling pathway in breast cancer. Yao CB; Zhou X; Chen CS; Lei QY Yi Chuan; 2017 Jul; 39(7):617-629. PubMed ID: 28757476 [TBL] [Abstract][Full Text] [Related]
10. [Under-expression of LATS1 promotes the differentiation, proliferation and migration of mesenchymal stem cells by inhibition the Hippo signaling pathway in vitro]. Li L; Dong L; Hui J; Gao F; Wang Q; Yang L; Zhang J; Yan J Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Aug; 29(8):731-737. PubMed ID: 28795673 [TBL] [Abstract][Full Text] [Related]
11. Induction of miR-15a expression by tripterygium glycosides caused premature ovarian failure by suppressing the Hippo-YAP/TAZ signaling effector Lats1. Ai A; Xiong Y; Wu B; Lin J; Huang Y; Cao Y; Liu T Gene; 2018 Dec; 678():155-163. PubMed ID: 30092342 [TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptors: bridging the gap from the extracellular signals to the Hippo pathway. Zhou X; Wang Z; Huang W; Lei QY Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):10-5. PubMed ID: 25491506 [TBL] [Abstract][Full Text] [Related]
13. Regulation of the Hippo-YAP pathway by G-protein-coupled receptor signaling. Yu FX; Zhao B; Panupinthu N; Jewell JL; Lian I; Wang LH; Zhao J; Yuan H; Tumaneng K; Li H; Fu XD; Mills GB; Guan KL Cell; 2012 Aug; 150(4):780-91. PubMed ID: 22863277 [TBL] [Abstract][Full Text] [Related]
14. Stiehopus japonieus acidic mucopolysaccharide inhibits the proliferation of pancreatic cancer SW1990 cells through Hippo-YAP pathway. Li X; Liu Y; Zhang C; Niu Q; Wang H; Che C; Xie M; Zhou B; Xu Y; Zhang Q; Wu J; Tian Z Oncotarget; 2017 Mar; 8(10):16356-16366. PubMed ID: 28099921 [TBL] [Abstract][Full Text] [Related]
15. Scutellarin Inhibits Proliferation, Invasion, and Tumorigenicity in Human Breast Cancer Cells by Regulating HIPPO-YAP Signaling Pathway. Hou L; Chen L; Fang L Med Sci Monit; 2017 Oct; 23():5130-5138. PubMed ID: 29079722 [TBL] [Abstract][Full Text] [Related]
16. The Hippo Pathway Regulates Caveolae Expression and Mediates Flow Response via Caveolae. Rausch V; Bostrom JR; Park J; Bravo IR; Feng Y; Hay DC; Link BA; Hansen CG Curr Biol; 2019 Jan; 29(2):242-255.e6. PubMed ID: 30595521 [TBL] [Abstract][Full Text] [Related]
17. DUB3 Deubiquitylating Enzymes Regulate Hippo Pathway Activity by Regulating the Stability of ITCH, LATS and AMOT Proteins. Nguyen HT; Kugler JM; Cohen SM PLoS One; 2017; 12(1):e0169587. PubMed ID: 28061504 [TBL] [Abstract][Full Text] [Related]
18. Estrogen regulates Hippo signaling via GPER in breast cancer. Zhou X; Wang S; Wang Z; Feng X; Liu P; Lv XB; Li F; Yu FX; Sun Y; Yuan H; Zhu H; Xiong Y; Lei QY; Guan KL J Clin Invest; 2015 May; 125(5):2123-35. PubMed ID: 25893606 [TBL] [Abstract][Full Text] [Related]
19. The N6-methyladenosine METTL3 regulates tumorigenesis and glycolysis by mediating m6A methylation of the tumor suppressor LATS1 in breast cancer. Xu Y; Song M; Hong Z; Chen W; Zhang Q; Zhou J; Yang C; He Z; Yu J; Peng X; Zhu Q; Li S; Ji K; Liu M; Zuo Q J Exp Clin Cancer Res; 2023 Jan; 42(1):10. PubMed ID: 36609396 [TBL] [Abstract][Full Text] [Related]
20. CD44 acts through RhoA to regulate YAP signaling. Zhang Y; Xia H; Ge X; Chen Q; Yuan D; Chen Q; Leng W; Chen L; Tang Q; Bi F Cell Signal; 2014 Nov; 26(11):2504-13. PubMed ID: 25101858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]